Alopecia Clinical Trials

Find clinical trials for Alopecia. Search for Alopecia clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 38

Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Winston-Salem

Code:

NCT04207931

Conditions

Central Centrifugal Cicatricial Alopecia (CCCA)

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Topical steroid class I-II

Triamcinolone Acetonide

Doxycyline

Minoxidil

Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata

Recruiting

EARLY_PHASE1

Sponsor:

The University of Texas Health Science Center, Houston

Location:

Houston

Code:

NCT05414266

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Interventions

Placebo

SADBE 5%

Safety and Efficacy of VDPHL01 in Males and Females with AGA

Recruiting

PHASE2

Sponsor:

Veradermics, Inc.

Location:

San Diego, New Albany, Hackensack, South Jordan

Code:

NCT06527365

Conditions

Androgenetic Alopecia

AGA

Male Pattern Baldness

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

VDPHL01

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Winston-Salem

Code:

NCT04764331

Conditions

Central Centrifugal Cicatricial Alopecia

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Revian Red All LED cap

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Recruiting

PHASE2

Sponsor:

Nektar Therapeutics

Location:

Northridge, Atlanta, Gurnee, Indianapolisshow 11 more

Code:

NCT06340360

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Rezpegaldesleukin

Placebo

Dupilumab in the Treatment of Pediatric Alopecia Areata

Recruiting

PHASE2

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Irvine, Chicago, New York

Code:

NCT05866562

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Placebo

Hydraderm for Androgenic Alopecia

Recruiting

Sponsor:

University of Minnesota

Location:

Minneapolis

Code:

NCT05426629

Conditions

Androgenic Alopecia

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Venus Glow

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Birmingham, Glendale, Phoenix, Fort Smithshow 72 more

Code:

NCT06012240

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 12 - 63

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Placebo

Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain

Recruiting

PHASE2

Sponsor:

Mitos Pharmaceuticals

Location:

Tucson, Philadelphia

Code:

NCT00801086

Conditions

Alopecia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

7% (w/v) Tempol alcohol-based gel (MTS-01)

alcohol-based gel

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Scottsdale, Fort Smith, Little Rock, Fountain Valleyshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted